The Hague, Netherlands

Michele Orlando



Average Co-Inventor Count = 6.8

ph-index = 5

Forward Citations = 94(Granted Patents)


Location History:

  • Giessen, DE (2009)
  • Munich, DE (2011 - 2012)
  • The Hague, NL (2009 - 2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michele Orlando

Introduction

Michele Orlando, an inventive force based in The Hague, Netherlands, has made significant strides in the field of biochemistry and pharmaceutical applications. With a portfolio of 8 patents to her name, she has proven to be a valuable asset in the realm of innovative solutions.

Latest Patents

Michele's latest patents showcase her expertise and innovative spirit. One key invention involves a method for coupling proteins to a starch-derived modified polysaccharide. This process utilizes a covalent bond formed through a coupling reaction, which plays a critical role in developing pharmaceutical compositions. The resulting conjugates have potential applications in the prophylaxis and therapy of both human and animal health.

Another significant patent features conjugates of hydroxyalkyl starch and protein, emphasizing the importance of covalent linkages in biopharmaceutical formulations. These advancements not only enhance the functionality of modified polysaccharides but also open new avenues in therapeutic applications.

Career Highlights

Currently, Michele is associated with Fresenius Kabi Deutschland GmbH, a leading global healthcare company. Her contributions to the field have earned her recognition not only for her technological advancements but also for her dedication to improving health outcomes through innovative research. Michele has developed a reputation for her ability to navigate complex biotechnological challenges, consistently delivering quality solutions.

Collaborations

Throughout her career, Michele has collaborated with several esteemed colleagues, including Wolfram Eichner and Klaus Sommermeyer. These partnerships have fostered a collaborative environment that encourages innovation and problem-solving. Their combined expertise in the field strengthens their contributions to the industry and enhances the overall impact of their research.

Conclusion

Michele Orlando stands out as an inventor dedicated to advancing biopharmaceutical technologies. Her patents reflect her commitment to innovation and her ability to develop cutting-edge solutions to complex challenges. As she continues to push the boundaries of biochemistry, Michele's work will undoubtedly contribute to important advancements in healthcare, marking her as a key player in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…